Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mamta Parikh

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Cancer Treatment and Research Communications|July 13, 2019
Breast cancer-specific survival in patients with HER2-positive, node-negative T1a and T1b breast cancerMamta Parikh, Maria Galkin, Ann Brunson, et al.
Currents in Pharmacy Teaching & Learning|April 28, 2022
Development of a survey to assess the impact of substance use disorder education on student pharmacists' perspectiveSimone Chebabo-Weiner, Stacey N Williams, Mamta Parikh, et al.
Clinical Genitourinary Cancer|January 5, 2023
ATR Inhibition in Advanced Urothelial CarcinomaRyan C Leibrandt, Mei-Juan Tu, Ai-Ming Yu, et al.
Clinical Genitourinary Cancer|March 10, 2026
Retrospective, Observational Analysis of Real-World Safety Outcomes in Patients With Locally Advanced/Metastatic Urothelial Cancer Treated With Sacituzumab GovitecanMamta Parikh, Peter McMahon, Susan Eng, et al.
Clinical Genitourinary Cancer|September 1, 2018
Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I StudyMamta Parikh, Chong-Xian Pan, Laurel A Beckett, et al.
Endocrine-Related Cancer|May 25, 2023
Prostate cancer and bone: clinical presentation and molecular mechanismsKristina V Wells, Margaret L Krackeler, Maitreyee K Jathal, et al.
Metabolites|March 24, 2022
Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in DogsMaria Malvina Tsamouri, Blythe P Durbin-Johnson, William T N Culp, et al.
Clinical Genitourinary Cancer|December 13, 2023
Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC)Nataliya Mar, Sami Dwabe, Marlon N Baranda, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Immunotherapy in synchronous MSI-H rectal adenocarcinoma and upper tract urothelial carcinoma: a case reportJacqueline Hsieh-Wong, James Liu, Jasmine Huynh, et al.
Journal of Adolescent and Young Adult Oncology|June 11, 2025
Association of Guideline-Concordant Care with Survival in Adolescent and Young Adult Patients with Germ Cell TumorsElysia Alvarez, Marcio Malogolowkin, A Lindsay Frazier, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Cancer Treatment and Research Communications|July 13, 2019
Breast cancer-specific survival in patients with HER2-positive, node-negative T1a and T1b breast cancerMamta Parikh, Maria Galkin, Ann Brunson, et al.
Currents in Pharmacy Teaching & Learning|April 28, 2022
Development of a survey to assess the impact of substance use disorder education on student pharmacists' perspectiveSimone Chebabo-Weiner, Stacey N Williams, Mamta Parikh, et al.
Clinical Genitourinary Cancer|January 5, 2023
ATR Inhibition in Advanced Urothelial CarcinomaRyan C Leibrandt, Mei-Juan Tu, Ai-Ming Yu, et al.
Clinical Genitourinary Cancer|March 10, 2026
Retrospective, Observational Analysis of Real-World Safety Outcomes in Patients With Locally Advanced/Metastatic Urothelial Cancer Treated With Sacituzumab GovitecanMamta Parikh, Peter McMahon, Susan Eng, et al.
Clinical Genitourinary Cancer|September 1, 2018
Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I StudyMamta Parikh, Chong-Xian Pan, Laurel A Beckett, et al.
Endocrine-Related Cancer|May 25, 2023
Prostate cancer and bone: clinical presentation and molecular mechanismsKristina V Wells, Margaret L Krackeler, Maitreyee K Jathal, et al.
Metabolites|March 24, 2022
Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in DogsMaria Malvina Tsamouri, Blythe P Durbin-Johnson, William T N Culp, et al.
Clinical Genitourinary Cancer|December 13, 2023
Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC)Nataliya Mar, Sami Dwabe, Marlon N Baranda, et al.
Journal of Gastrointestinal Oncology|July 15, 2022
Immunotherapy in synchronous MSI-H rectal adenocarcinoma and upper tract urothelial carcinoma: a case reportJacqueline Hsieh-Wong, James Liu, Jasmine Huynh, et al.
Journal of Adolescent and Young Adult Oncology|June 11, 2025
Association of Guideline-Concordant Care with Survival in Adolescent and Young Adult Patients with Germ Cell TumorsElysia Alvarez, Marcio Malogolowkin, A Lindsay Frazier, et al.
Pageof 5